Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

Summary

This is a multicenter, single-dose, open-label, parallel Phase 1 clinical study to evaluate the PK profile, safety, and tolerability of GZR4 Injection in subjects with mild, moderate, and severe hepatic impairment.

Timeline

Start

2025-10-20

Primary completion

2026-07-14

Completion

2026-11-04

Drugs

Indications